Gonococcal vulvovaginitis, unspecified
ICD-10 A54.02 is a billable code used to indicate a diagnosis of gonococcal vulvovaginitis, unspecified.
Gonococcal vulvovaginitis is an infection of the vulva and vagina caused by the bacterium Neisseria gonorrhoeae, a common sexually transmitted infection (STI). This condition is characterized by inflammation of the vulva and vagina, which may present with symptoms such as itching, burning, and abnormal discharge. The infection can occur in both symptomatic and asymptomatic individuals, making it crucial for healthcare providers to consider it in sexually active patients presenting with vulvovaginal symptoms. Gonococcal vulvovaginitis can lead to more severe complications if left untreated, including pelvic inflammatory disease (PID) and infertility. Diagnosis typically involves laboratory testing, including nucleic acid amplification tests (NAATs) or culture methods. Treatment usually consists of antibiotic therapy, with the Centers for Disease Control and Prevention (CDC) recommending dual therapy with ceftriaxone and azithromycin to effectively combat potential antibiotic resistance. Contact tracing is essential to prevent reinfection and further spread of the disease, emphasizing the importance of notifying sexual partners for testing and treatment. Given the potential for asymptomatic cases, routine screening in high-risk populations is recommended.
Detailed documentation of symptoms, laboratory results, and treatment plans is essential.
Patients presenting with vulvovaginal itching, discharge, or pelvic pain.
Consideration of co-existing STIs and the need for partner notification.
Comprehensive history of sexual activity and previous STI history.
Management of complicated gonococcal infections and antibiotic resistance.
Monitoring for treatment efficacy and potential complications.
Used for confirming diagnosis in symptomatic patients.
Document the reason for testing and results.
Ensure proper specimen collection and handling.
Common symptoms include vulvar itching, burning sensation, abnormal discharge, and pelvic pain. Some individuals may be asymptomatic.